Letters
Publication of all trial results
Research ethics committees have the power to enforce publication of drug trial results
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1201 (Published 26 February 2013) Cite this as: BMJ 2013;346:f1201
- Alan S Edwards, retired company director1
- 1Essex Research Ethics Committee, Downham, UK
- the_edwards_family{at}hotmail.com
It seems to me that research ethics committees (RECs) have much more power than medical journals to enforce a higher publication rate by drug companies.1 RECs guard the gateway to patient trials that drug companies badly want, so they have a strong bargaining position.
Yet RECs seem unwilling to step up to their responsibilities, viewing themselves …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.